FT Options LLC historic quarter change: USA Other Stocks, Added
In shares no fund filing gives a ticker for, so this site has no page for them (listed in the US), over 3 quarters from 2015-12-31 to 2016-09-30, FT Options LLC opened 57 positions, added to 26, reduced 28 and sold out of 61.
- Q3 2016: Stock CLOVIS ONCOLOGY INC; Country of operation —; Class COM; Shares before 5,190.
- Q3 2016: Stock BANK OF THE OZARKS INC; Country of operation —; Class COM; Shares before 2,500.
- Q3 2016: Stock INOTEK PHARMACEUTICALS CORP; Country of operation —; Class COM; Shares before 144,751.
- Q3 2016: Stock SAGE THERAPEUTICS INC; Country of operation United States; Class COM; Shares before 8,773.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1594954), 3 quarters: Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-10); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-12); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-09). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2015-12-31.
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q3 2016 | CLOVIS ONCOLOGY INC
CUSIP 189464100 | | COM | 5,190 | 71,091 | +65,901 | $71,000 | $2,563,000 | +$2,492,000 | 2016-11-10 |
|---|
| Q3 2016 | BANK OF THE OZARKS INC
CUSIP 063904106 | | COM | 2,500 | 23,675 | +21,175 | $94,000 | $909,000 | +$815,000 | 2016-11-10 |
|---|
| Q3 2016 | INOTEK PHARMACEUTICALS CORP
CUSIP 45780V102 | | COM | 144,751 | 156,864 | +12,113 | $1,077,000 | $1,487,000 | +$410,000 | 2016-11-10 |
|---|
| Q3 2016 | SAGE THERAPEUTICS INC
CUSIP 78667J108 | United States | COM | 8,773 | 12,778 | +4,005 | $264,000 | $588,000 | +$324,000 | 2016-11-10 |
|---|
| Q3 2016 | ZAFGEN INC
CUSIP 98885E103 | | COM | 24,930 | 131,930 | +107,000 | $149,000 | $437,000 | +$288,000 | 2016-11-10 |
|---|
| Q3 2016 | NII HLDGS INC
CUSIP 62913F508 | United States | COM PAR $0.001 | 30,000 | 55,000 | +25,000 | $95,000 | $183,000 | +$88,000 | 2016-11-10 |
|---|
| Q3 2016 | CATABASIS PHARMACEUTICALS IN
CUSIP 14875P107 | | COM | 15,059 | 17,736 | +2,677 | $56,000 | $109,000 | +$53,000 | 2016-11-10 |
|---|
| Q3 2016 | PAIN THERAPEUTICS INC
CUSIP 69562K100 | | COM | 35,262 | 43,500 | +8,238 | $77,000 | $43,000 | -$34,000 | 2016-11-10 |
|---|
| Q2 2016 | MEDIVATION INC
CUSIP 58501N101 | | COM | 38,155 | 119,135 | +80,980 | $1,754,000 | $7,184,000 | +$5,430,000 | 2016-08-12 |
|---|
| Q2 2016 | YAHOO INC
CUSIP 984332106 | | COM | 5,241 | 30,341 | +25,100 | $193,000 | $1,140,000 | +$947,000 | 2016-08-12 |
|---|
| Q2 2016 | OTONOMY INC
CUSIP 68906L105 | United States | COM | 156,437 | 192,785 | +36,348 | $2,334,000 | $3,061,000 | +$727,000 | 2016-08-12 |
|---|
| Q2 2016 | POTASH CORP SASK INC
CUSIP 73755L107 | | COM | 60,000 | 96,080 | +36,080 | $1,021,000 | $1,560,000 | +$539,000 | 2016-08-12 |
|---|
| Q2 2016 | ALLERGAN PLC
CUSIP G0177J108 | | SHS | 1,480 | 4,038 | +2,558 | $397,000 | $933,000 | +$536,000 | 2016-08-12 |
|---|
| Q2 2016 | ALEXION PHARMACEUTICALS INC
CUSIP 015351109 | | COM | 3,573 | 8,673 | +5,100 | $497,000 | $1,013,000 | +$516,000 | 2016-08-12 |
|---|
| Q2 2016 | ALERE INC
CUSIP 01449J105 | | COM | 36,163 | 53,163 | +17,000 | $1,830,000 | $2,216,000 | +$386,000 | 2016-08-12 |
|---|
| Q2 2016 | NEWLINK GENETICS CORP
CUSIP 651511107 | | COM | 21,003 | 21,903 | +900 | $382,000 | $247,000 | -$135,000 | 2016-08-12 |
|---|
| Q2 2016 | SCYNEXIS INC
CUSIP 811292101 | | COM | 55,130 | 155,912 | +100,782 | $222,000 | $338,000 | +$116,000 | 2016-08-12 |
|---|
| Q2 2016 | NII HLDGS INC
CUSIP 62913F508 | United States | COM PAR $0.001 | 10,000 | 30,000 | +20,000 | $55,000 | $95,000 | +$40,000 | 2016-08-12 |
|---|
| Q1 2016 | INOTEK PHARMACEUTICALS CORP
CUSIP 45780V102 | | COM | 26,421 | 169,551 | +143,130 | $299,000 | $1,255,000 | +$956,000 | 2016-05-09 |
|---|
| Q1 2016 | ONCOTHYREON INC
CUSIP 682324108 | | COM | 300,011 | 1,015,607 | +715,596 | $666,000 | $1,290,000 | +$624,000 | 2016-05-09 |
|---|
| Q1 2016 | E M C CORP MASS
CUSIP 268648102 | | COM | 10,000 | 22,500 | +12,500 | $257,000 | $600,000 | +$343,000 | 2016-05-09 |
|---|
| Q1 2016 | FIVE PRIME THERAPEUTICS INC
CUSIP 33830X104 | | COM | 10,505 | 15,312 | +4,807 | $436,000 | $622,000 | +$186,000 | 2016-05-09 |
|---|
| Q1 2016 | ALDER BIOPHARMACEUTICALS INC
CUSIP 014339105 | | COM | 8,716 | 16,173 | +7,457 | $288,000 | $396,000 | +$108,000 | 2016-05-09 |
|---|
| Q1 2016 | CHIMERIX INC
CUSIP 16934W106 | United States | COM | 154,100 | 287,712 | +133,612 | $1,379,000 | $1,470,000 | +$91,000 | 2016-05-09 |
|---|
| Q1 2016 | ARROWHEAD RESH CORP
CUSIP 042797209 | | COM NEW | 51,847 | 79,705 | +27,858 | $319,000 | $384,000 | +$65,000 | 2016-05-09 |
|---|
| Q1 2016 | SCYNEXIS INC
CUSIP 811292101 | | COM | 37,875 | 55,130 | +17,255 | $235,000 | $222,000 | -$13,000 | 2016-05-09 |
|---|
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|
| Not available yet |